OTCMKTS:NEVPF - NeuroVive Pharmaceutical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.1534 0.00 (0.00 %) (As of 05/24/2019 04:00 PM ET)Previous Close$0.1534Today's Range$0.1196 - $0.158252-Week Range$0.0988 - $0.6688Volume14,666 shsAverage Volume11,034 shsMarket Capitalization$8.03 millionP/E RatioN/ADividend YieldN/ABeta2.31 ProfileChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NeuroVive Pharmaceutical AB (publ) engages in the research and development of mitochondrial medicine in Sweden and internationally. Its product portfolio includes NeuroSTAT, a drug candidate that is in phase II clinical trial for the treatment of traumatic brain injuries; and KL1333 that is in phase I clinical trial for the treatment of genetic mitochondrial diseases. The company also develops NVP015/NV354 drug candidates for mitochondrial diseases; NVP025 drug candidate for mitochondrial myopathies; NV556 and NVP022 drug candidates for non-alcoholic steatohepatitis conditions; and NVP024, a hepatocellular carcinoma program. NeuroVive Pharmaceutical AB (publ) has collaboration agreements with Isomerase Therapeutics, Sihuan Pharmaceutical, and Sanofi Korea. The company also has a preclinical collaboration agreement with the Children's Hospital of Philadelphia for research in genetic mitochondrial disorders. NeuroVive Pharmaceutical AB (publ) was founded in 2000 and is headquartered in Lund, Sweden. Receive NEVPF News and Ratings via Email Sign-up to receive the latest news and ratings for NEVPF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:NEVPF Previous Symbol CUSIPN/A CIKN/A Webhttp://www.neurovive.com/ Phone46-4-627-562-20Debt Debt-to-Equity RatioN/A Current Ratio1.56 Quick Ratio1.56Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.21 per share Price / Book0.73Profitability EPS (Most Recent Fiscal Year)($0.11) Net Income$-7,870,000.00 Net MarginsN/A Return on Equity-61.92% Return on Assets-54.40%Miscellaneous Employees7 Outstanding Shares52,326,000Market Cap$8.03 million Next Earnings Date5/28/2019 (Estimated) OptionableNot Optionable NeuroVive Pharmaceutical (OTCMKTS:NEVPF) Frequently Asked Questions What is NeuroVive Pharmaceutical's stock symbol? NeuroVive Pharmaceutical trades on the OTCMKTS under the ticker symbol "NEVPF." How were NeuroVive Pharmaceutical's earnings last quarter? NeuroVive Pharmaceutical AB (OTCMKTS:NEVPF) released its quarterly earnings results on Monday, March, 25th. The company reported ($0.02) EPS for the quarter. View NeuroVive Pharmaceutical's Earnings History. When is NeuroVive Pharmaceutical's next earnings date? NeuroVive Pharmaceutical is scheduled to release their next quarterly earnings announcement on Tuesday, May 28th 2019. View Earnings Estimates for NeuroVive Pharmaceutical. Has NeuroVive Pharmaceutical been receiving favorable news coverage? News articles about NEVPF stock have been trending positive on Saturday, InfoTrie reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. NeuroVive Pharmaceutical earned a daily sentiment score of 2.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. Who are some of NeuroVive Pharmaceutical's key competitors? Some companies that are related to NeuroVive Pharmaceutical include Aptevo Therapeutics (APVO), Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (ZOM), ContraFect (CFRX), Sernova (SEOVF), Helix Biopharma (HBPCF), ProMetic Life Sciences (PFSCF), Citius Pharmaceuticals (CTXR), Acerus Pharmaceuticals (TRLPF), Acerus Pharmaceuticals (ASPCF), Regulus Therapeutics (RGLS), Conatus Pharmaceuticals (CNAT), MOTIF BIO PLC/S (MTFB), Addex Therapeutics (ADDXF), RegeneRx Biopharmaceuticals (RGRX) and Heat Biologics (HTBX). What other stocks do shareholders of NeuroVive Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some companies that other NeuroVive Pharmaceutical investors own include Allena Pharmaceuticals (ALNA), Okta (OKTA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP), Ardelyx (ARDX) and ArQule (ARQL). Who are NeuroVive Pharmaceutical's key executives? NeuroVive Pharmaceutical's management team includes the folowing people: Mr. Erik Kinnmann M.D., Ph.D., M.B.A., Assoc. Prof., Chief Exec. Officer (Age 61)Ms. Catharina Jz Johansson, CFO & VP of Investor Relations (Age 52)Dr. Eskil Elmér, Chief Scientific Officer & VP of Discovery (Age 49)Daniel Schale, Director of CommunicationsDr. Magnus Hansson, Chief Medical Officer and VP of Preclinical & Clinical Devel. (Age 43) How do I buy shares of NeuroVive Pharmaceutical? Shares of NEVPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is NeuroVive Pharmaceutical's stock price today? One share of NEVPF stock can currently be purchased for approximately $0.1534. How big of a company is NeuroVive Pharmaceutical? NeuroVive Pharmaceutical has a market capitalization of $8.03 million. The company earns $-7,870,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. NeuroVive Pharmaceutical employs 7 workers across the globe. What is NeuroVive Pharmaceutical's official website? The official website for NeuroVive Pharmaceutical is http://www.neurovive.com/. How can I contact NeuroVive Pharmaceutical? NeuroVive Pharmaceutical's mailing address is MEDICON VILLAGE SCHEELEVAGEN 2, LUND V7, 223 81. The company can be reached via phone at 46-4-627-562-20 or via email at [email protected] MarketBeat Community Rating for NeuroVive Pharmaceutical (OTCMKTS NEVPF)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 54 (Vote Outperform)Underperform Votes: 52 (Vote Underperform)Total Votes: 106MarketBeat's community ratings are surveys of what our community members think about NeuroVive Pharmaceutical and other stocks. Vote "Outperform" if you believe NEVPF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEVPF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/25/2019 by MarketBeat.com StaffFeatured Article: Differences Between Momentum Investing and Long Term Investing Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.